Ablation or Antiarrhythmics for Ventricular Tachycardia?
CardiacWire
NOVEMBER 20, 2024
Late-breaking results from the VANISH2 trial presented at AHA 2024 showed that catheter ablation might be a better first-line treatment than antiarrhythmic drugs for ventricular tachycardia patients with ischemic cardiomyopathy. However, it’s unproven whether catheter ablation is more effective than antiarrhythmics as a first-line treatment.
Let's personalize your content